Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Open accessThe DOI matches its Crossref record.
Abstract
Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Still being checked.
Cited by
Mechanism of Action of Trazodone:a Multifunctional Drug
Stahl, S. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900024020 · Cited by 266
Self-citationA new three-dimensional model for emotions and monoamine neurotransmitters
Lövheim, H. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.016 · Cited by 357
Stahl, S. M., Sommer, B., & Allers, K. A. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02032.x · Cited by 293
Self-citationStahl, S. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017089 · Cited by 241
Self-citationRediscovering Trazodone for the Treatment of Major Depressive Disorder
Fagiolini, A., Comandini, A., Dell’Osso, M. C., & Kasper, S. (2012) · CNS Drugs · doi:10.1007/s40263-012-0010-5 · Cited by 228
L-Methylfolate: A Vitamin for Your Monoamines: (Brainstorms)
Stahl, S. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0901 · Cited by 238
Self-citationStahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000407 · Cited by 221
Self-citationMechanism of action of ketamine
Stahl, S. M. (2013) · CNS Spectrums · doi:10.1017/s109285291300045x · Cited by 52
Self-citationMonoamine Oxidase Inhibitors:A Modern Guide to an Unrequited Class of Antidepressants
Stahl, S. M., & Felker, A. (2008) · CNS Spectrums · doi:10.1017/s1092852900016965 · Cited by 191
Self-citationStahl, S. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000248 · Cited by 193
Self-citationStahl, S. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000637 · Cited by 179
Self-citationClinically Significant Drug Interactions with Newer Antidepressants
Spina, E., Trifirò, G., & Caraci, F. (2012) · CNS Drugs · doi:10.2165/11594710-000000000-00000 · Cited by 160
Jowf, G. I. A., Ahmed, Z. T., Reijnders, R. A., de Nijs, L., & Eijssen, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065238 · Cited by 167
Molecular aspects of depression: A review from neurobiology to treatment
Villas Boas, G. R., Boerngen de Lacerda, R., Paes, M. M., Gubert, P., Almeida, W. L. D. C., Rescia, V. C., de Carvalho, P. M. G., de Carvalho, A. A. V., & Oesterreich, S. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.024 · Cited by 128
Neurocognitive Functioning in Depressed Young People: A Systematic Review and Meta-Analysis
Goodall, J., Fisher, C., Hetrick, S., Phillips, L., Parrish, E. M., & Allott, K. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9373-9 · Cited by 121
Clinically relevant interactions between newer antidepressants and second-generation antipsychotics
Spina, E., & de León, J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.885504 · Cited by 136
Mechanism of action of cariprazine
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000043 · Cited by 126
Self-citationKanner, A. M. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.03.022 · Cited by 128
Neuroethical issues in cognitive enhancement
Sahakian, B. J., & Morein-Zamir, S. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106926 · Cited by 109
Hamilton, G. F., Whitcher, L. T., & Klintsova, A. Y. (2010) · Synapse · doi:10.1002/syn.20711 · Cited by 98
Grassi, L., Caruso, R., Hammelef, K., Nanni, M. G., & Riba, M. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.842542 · Cited by 101
Association between suicidal behaviour and impaired glucose metabolism in depressive disorders
Koponen, H., Kautiainen, H., Leppänen, E., Mäntyselkä, P., & Vanhala, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0567-x · Cited by 102
Spina, E., Pisani, F., & de León, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.014 · Cited by 113
Mechanism of action of brexpiprazole: comparison with aripiprazole
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852915000954 · Cited by 116
Self-citationAbuse and misuse of antidepressants
Sullivan, M., & Evans, E. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s37917 · Cited by 91
Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement
Stute, P., Spyropoulou, A. C., Karageorgiou, V., Cano, A., Bitzer, J., Ceauşu, I., Chedraui, P. A., Durmuşoğlu, F., Erkkola, R. U., Goulis, D. G., et al. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.11.002 · Cited by 110
Histamine-1 receptor antagonism for treatment of insomnia
Vande Griend, J. P., & Anderson, S. L. (2012) · Journal of the American Pharmacists Association · doi:10.1331/japha.2012.12051 · Cited by 79
Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives
Wolf, C., Curry, A., Nacht, J., & Simpson, S. A. (2020) · Open Access Emergency Medicine · doi:10.2147/oaem.s235288 · Cited by 93
Mandal, P. K., Gaur, S., Roy, R. G., Samkaria, A., Ingole, R., & Goel, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00420 · Cited by 88
Caraci, F., Crupi, R., Drago, F., & Spina, E. (2011) · Current Drug Metabolism · doi:10.2174/138920011795713706 · Cited by 80
“Meta-guidelines” for the management of patients with schizophrenia
Stahl, S. M., Morrissette, D. A., Citrome, L., Saklad, S. R., Cummings, M. A., Meyer, J. M., O'Day, J. A., Dardashti, L. J., & Warburton, K. D. (2013) · CNS Spectrums · doi:10.1017/s109285291300014x · Cited by 83
Self-citationClonidine Use in Psychiatry: Panacea or Panache?
Naguy, A. (2016) · Pharmacology · doi:10.1159/000446441 · Cited by 76
Drugs related to monoamine oxidase activity
Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 78
Stahl, S. M. (2015) · CNS Spectrums · doi:10.1017/s1092852915000139 · Cited by 77
Self-citationModulating the serotonin system in the treatment of major depressive disorder
Morrissette, D. A., & Stahl, S. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000613 · Cited by 64
Self-citationMontastruc, F., Palmaro, A., Bagheri, H., Schmitt, L., Montastruc, J., & Lapeyre‐Mestre, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.010 · Cited by 68
Parkinson’s disease psychosis as a serotonin-dopamine imbalance syndrome
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000602 · Cited by 67
Self-citationNovel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
Edinoff, A. N., Nix, C. A., Odisho, A. S., Babin, C. P., Derouen, A. G., Lutfallah, S. C., Cornett, E. M., Murnane, K. S., Kaye, A. M., & Kaye, A. D. (2022) · Neurology International · doi:10.3390/neurolint14030053 · Cited by 74
Frodl, T., Scheuerecker, J., Schoepf, V., Linn, J., Koutsouleris, N., Bokde, A. L. W., Hampel, H., Möller, H.-J., Brückmann, H., Wiesmann, M., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05393blu · Cited by 62
Stahl, S. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000522 · Cited by 63
Self-citationOlanzapine: review of safety 2008
Kantrowitz, J. T., & Citrome, L. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802423234 · Cited by 67
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
Vanegas‐Arroyave, N., Caroff, S. N., Citrome, L., Crasta, J., McIntyre, R. S., Meyer, J. M., Patel, A., Smith, J. M., Farahmand, K., Manahan, R., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01078-z · Cited by 66
Pharmacological Treatment of Obsessive-Compulsive Disorder
Simpson, H. B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_12 · Cited by 59
Langley, C., Armand, S., Luo, Q., Savulich, G., Segerberg, T., Søndergaard, A., Pedersen, E. B., Svart, N., Overgaard-Hansen, O., Johansen, A., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01523-x · Cited by 58
New Developments in the Treatment of Schizophrenia: An Expert Roundtable
Kantrowitz, J. T., Correll, C. U., Jain, R., & Cutler, A. J. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad011 · Cited by 57
Cho, S., Yook, K., Kim, B., Choi, T. K., Lee, K. S., Kim, Y. W., Lee, J. E., Suh, S.-Y., Yook, K. H., & Lee, S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.006 · Cited by 57
Multifunctional Drugs: A Novel Concept for Psychopharmacology
Stahl, S. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900000213 · Cited by 49
Self-citationVerbeeck, W., Tuinier, S., & Bekkering, G. E. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0008-7 · Cited by 59
Seppälä, J., Koponen, H., Kautiainen, H., Eriksson, J. G., Kampman, O., Leiviskä, J., Männistö, S., Mäntyselkä, P. T., Oksa, H. H., Ovaskainen, Y., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-145 · Cited by 50
Gheysens, T., Eede, F. V. D., & Picker, L. D. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.11 · Cited by 54
Aripiprazole: A new risk factor for pathological gambling? A report of 8 case reports
Gaboriau, L., Victorri‐Vigneau, C., Gérardin, M., Allain-Veyrac, G., Jolliet, P., & Grall‐Bronnec, M. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.005 · Cited by 46
Laoutidis, Z. G., & Luckhaus, C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001417 · Cited by 46
Stahl, S. M., Sy, S., & Maguire, G. A. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13266 · Cited by 49
Self-citationDolder, C. R., Nelson, M., & Stump, A. (2010) · Drugs & Aging · doi:10.2165/11537140-000000000-00000 · Cited by 48
Halmai, Z., Döme, P., Dobos, J., Gonda, X., Székely, A., Sasvári‐Székely, M., Faludi, G., & Lazáry, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.006 · Cited by 42
Sato, H., Ito, C., Hiraoka, K., Tashiro, M., Shibuya, K., Funaki, Y., Yoshikawa, T., Iwata, R., Matsuoka, H., & Yanai, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4002-2 · Cited by 46
Li, H., Yao, C., Shi, J., Yang, F., Qi, S., Wang, L., Zhang, H., Li, J., Wang, C., Wang, C., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.07.015 · Cited by 39
Lin, K., Cherng, C. G., Yang, F.-R., Lin, L.-C., Lu, R., & Yu, L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.031 · Cited by 39
Depression and pain: often together but still a clinical challenge: a review.
Rijavec, N., & Novak-Grubic, V. (2012) · PubMed · Cited by 39
Williams, A. A., Ingram, W. M., Levine, S., Resnik, J., Kamel, C. M., Lish, J. R., Elizalde, D. I., Janowski, S. A., Shoker, J., Kozlenkov, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.81 · Cited by 40
Trifirò, G., Sultana, J., & Spina, E. (2014) · Drug Safety · doi:10.1007/s40264-014-0170-y · Cited by 41
Morrissette, D. A., & Stahl, S. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000388 · Cited by 39
Self-citationMoncrieff, J. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000555 · Cited by 41
Divergent suicidal symptomatic activations converge on somato-cognitive action network in depression
Li, J., Wang, D., Xia, J., Zhang, C., Meng, Y., Xu, S., Chen, H., & Liao, W. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02450-7 · Cited by 39
Posttraumatic Stress in Older Adults
Moye, J. A., & Rouse, S. J. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.006 · Cited by 38
Stahl, S. M. (2015) · CNS Spectrums · doi:10.1017/s1092852915000346 · Cited by 40
Self-citationNondopaminergic neurotransmission in the pathophysiology of Tourette syndrome.
Udvardi, P. T., Nespoli, E., Rizzo, F., Hengerer, B., & Ludolph, A. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00004-4 · Cited by 33
Underlying mechanisms of mindfulness meditation: Genomics, circuits, and networks
Gu, Y., & Zhu, Y. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i9.1141 · Cited by 38
Castle, D. J., Copolov, D., SINGH, B. S., & Bastiampillai, T. J. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231209840 · Cited by 36
Stahl, S. M. (2015) · CNS Spectrums · doi:10.1017/s1092852915000334 · Cited by 41
Self-citationStahl, S. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1101 · Cited by 36
Self-citationCitrome, L. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.693160 · Cited by 36
The Serotonin-7 Receptor as a Novel Therapeutic Target
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10bs06601gry · Cited by 35
Self-citationDosing Atypical Antipsychotics
Cutler, A. J., Ball, S., & Stahl, S. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900003035 · Cited by 35
Self-citationOptimizing treatment for older adults with depression
Srifuengfung, M., Pennington, B. R. T., & Lenze, E. J. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231212327 · Cited by 39
Nuevas guías para el uso de la polifarmacia antipsicótica
Stahl, S. M. (2013) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2013.01.001 · Cited by 34
Self-citationMechanism of Action of Stimulants in Attention-Deficit/Hyperactivity Disorder: (Brainstorms)
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09bs05890pur · Cited by 34
Self-citationNovel Compounds in the Treatment of Schizophrenia—A Selective Review
Diakaki, K., Miliaras, A., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2023) · Brain Sciences · doi:10.3390/brainsci13081193 · Cited by 37
Circuits of Sexual Desire in Hypoactive Sexual Desire Disorder
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10bs06115whi · Cited by 33
Self-citationRogóż, Z. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71499-3 · Cited by 35
Stahl, S. M. (2015) · CNS Spectrums · doi:10.1017/s1092852915000358 · Cited by 33
Self-citationKisielewska, W., Kościółek, M., Kowalczyk, W., Mitura, B., Mitura, L., Rogula, S., Leszczyński, P., Antosik, K., & Mitura, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092940 · Cited by 38
Dong, B. E., Chen, H., & Sakata, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15017 · Cited by 33
Seo, M. K., Lee, C. H., Cho, H. Y., You, Y. S., Lee, B. J., Lee, J. G., Park, S. W., & Kim, Y. H. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.098 · Cited by 32
Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Carbray, J. A. (2018) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20181112-02 · Cited by 31
Psychedelic therapy in depression and substance use disorders
Korkmaz, N. D., Çıkrıkçılı, U., Akan, M., & Yücesan, E. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16421 · Cited by 32
Tarchi, L., Merola, G. P., Boy, O. B., Arganini, F., Cassioli, E., Rossi, E., Maggi, M., Baldwin, D. S., Ricca, V., & Castellini, G. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5653 · Cited by 29
Undisclosed conflicts of interest among biomedical textbook authors
Piper, B. J., Lambert, D. A., Keefe, R. C., Smukler, P. U., Selemon, N. A., & Duperry, Z. R. (2018) · AJOB Empirical Bioethics · doi:10.1080/23294515.2018.1436095 · Cited by 28
Targeting Circuits of Sexual Desire as a Treatment Strategy for Hypoactive Sexual Desire Disorder
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10bs06117blu · Cited by 28
Self-citationStahl, S. M., Davis, R. L., Kim, D. H., Lowe, N. G., Carlson, R. E., Fountain, K., & Grady, M. M. (2010) · CNS Spectrums · doi:10.1017/s1092852900000444 · Cited by 41
Self-citationGruen, M. E., Roe, S. C., Griffith, E. H., & Sherman, B. L. (2017) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2017.09.008 · Cited by 28
Plesničar, B. K., Terzić, T., Kastelic, M., & Dolžan, V. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s76494 · Cited by 31
Subtyping schizophrenia: A comparison of positive/negative and system-specific approaches
Lang, F. U., Walther, S., Stegmayer, K., Anderson‐Schmidt, H., Schulze, T. G., Becker, T. M., & Jäger, M. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.05.014 · Cited by 28
Curry, D. E., & Richards, B. L. (2022) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2022.180207 · Cited by 30
[Mechanism of action of ketamine].
Vl, V., Tg, E., Vi, A., & Sp, N. (1983) · PubMed · Cited by 27
Kuzenko, N., Sareen, J., Beesdo‐Baum, K., Perkonigg, A., Höfler, M., Simm, J., Lieb, R., & Wïttchen, H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01633.x · Cited by 30
Stahl, S. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000084 · Cited by 26
Self-citationZhukovsky, P., Alsiö, J., Jupp, B., Xia, J., Guiliano, C., Jenner, L., Griffiths, J., Riley, E., Ali, S., Roberts, A., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4569-x · Cited by 27
Mörstedt, B., Corbisiero, S., Bitto, H., & Stieglitz, R. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0181-2 · Cited by 32
Sakuma, K., Komatsu, H., Maruyama, M., Imaichi, S., Habata, Y., & Mori, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118510 · Cited by 27
Metadata
- Authors
- Stahl, S. M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Stahl, Stephen M.
- ORCID
- Stahl, Stephen M.
- Venue
- Cambridge University Press eBooks
- Publisher
- Cambridge University Press
- Published
- 2021-07-29
- OpenAlex
- W3210183659
- Cited by
- 480
- References
- 0
- Citations by year
- 2026: 63 · 2025: 56 · 2024: 75 · 2023: 55 · 2022: 30 · 2021: 5
- FWCI
- 40.47
- Type
- book
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cambridge University Press eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- psychopharmacology, psychiatric medication, drug mechanisms, mental illness, Parkinson's disease psychosis, medical cannabis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.